Neurodevelopment in schizophrenia: The role of the wnt pathways

Isabella Panaccione, Flavia Napoletano, Alberto Maria Forte, Giorgio D. Kotzalidis, Antonio Del Casale, Chiara Rapinesi, Chiara Brugnoli, Daniele Serata, Federica Caccia, Ilaria Cuomo, Elisa Ambrosi, Alessio Simonetti, Valeria Savoja, Lavinia De Chiara, Emanuela Danese, Giovanni Manfredi, Delfina Janiri, Marta Motolese, Ferdinando Nicoletti, Paolo GirardiGabriele Sani

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objectives. To review the role of Wnt pathways in the neurodevelopment of schizophrenia. Methods: Systematic PubMed search, using as keywords all the terms related to the Wnt pathways and crossing them with each of the following areas: normal neurodevelopment and physiology, neurodevelopmental theory of schizophrenia, schizophrenia, and antipsychotic drug action. Results: Neurodevelopmental, behavioural, genetic, and psychopharmacological data point to the possible involvement of Wnt systems, especially the canonical pathway, in the pathophysiology of schizophrenia and in the mechanism of antipsychotic drug action. The molecules most consistently found to be associated with abnormalities or in antipsychotic drug action are Akt1, glycogen synthase kinase3beta, and beta-catenin. However, the extent to which they contribute to the pathophysiology of schizophrenia or to antipsychotic action remains to be established. Conclusions: The study of the involvement of Wnt pathway abnormalities in schizophrenia may help in understanding this multifaceted clinical entity; the development of Wnt-related pharmacological targets must await the collection of more data.

Original languageEnglish
Pages (from-to)535-558
Number of pages24
JournalCurrent Neuropharmacology
Volume11
Issue number5
DOIs
Publication statusPublished - Sep 2013

Fingerprint

Wnt Signaling Pathway
Schizophrenia
Antipsychotic Agents
Behavioral Genetics
Glycogen Synthase
beta Catenin
PubMed
Pharmacology

Keywords

  • Antipsychotic drugs
  • Neurodevelopment
  • Schizophrenia
  • Wingless (wnt) signalling

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Pharmacology
  • Neurology
  • Psychiatry and Mental health

Cite this

Panaccione, I., Napoletano, F., Forte, A. M., Kotzalidis, G. D., Del Casale, A., Rapinesi, C., ... Sani, G. (2013). Neurodevelopment in schizophrenia: The role of the wnt pathways. Current Neuropharmacology, 11(5), 535-558. https://doi.org/10.2174/1570159X113119990037

Neurodevelopment in schizophrenia : The role of the wnt pathways. / Panaccione, Isabella; Napoletano, Flavia; Forte, Alberto Maria; Kotzalidis, Giorgio D.; Del Casale, Antonio; Rapinesi, Chiara; Brugnoli, Chiara; Serata, Daniele; Caccia, Federica; Cuomo, Ilaria; Ambrosi, Elisa; Simonetti, Alessio; Savoja, Valeria; De Chiara, Lavinia; Danese, Emanuela; Manfredi, Giovanni; Janiri, Delfina; Motolese, Marta; Nicoletti, Ferdinando; Girardi, Paolo; Sani, Gabriele.

In: Current Neuropharmacology, Vol. 11, No. 5, 09.2013, p. 535-558.

Research output: Contribution to journalArticle

Panaccione, I, Napoletano, F, Forte, AM, Kotzalidis, GD, Del Casale, A, Rapinesi, C, Brugnoli, C, Serata, D, Caccia, F, Cuomo, I, Ambrosi, E, Simonetti, A, Savoja, V, De Chiara, L, Danese, E, Manfredi, G, Janiri, D, Motolese, M, Nicoletti, F, Girardi, P & Sani, G 2013, 'Neurodevelopment in schizophrenia: The role of the wnt pathways', Current Neuropharmacology, vol. 11, no. 5, pp. 535-558. https://doi.org/10.2174/1570159X113119990037
Panaccione I, Napoletano F, Forte AM, Kotzalidis GD, Del Casale A, Rapinesi C et al. Neurodevelopment in schizophrenia: The role of the wnt pathways. Current Neuropharmacology. 2013 Sep;11(5):535-558. https://doi.org/10.2174/1570159X113119990037
Panaccione, Isabella ; Napoletano, Flavia ; Forte, Alberto Maria ; Kotzalidis, Giorgio D. ; Del Casale, Antonio ; Rapinesi, Chiara ; Brugnoli, Chiara ; Serata, Daniele ; Caccia, Federica ; Cuomo, Ilaria ; Ambrosi, Elisa ; Simonetti, Alessio ; Savoja, Valeria ; De Chiara, Lavinia ; Danese, Emanuela ; Manfredi, Giovanni ; Janiri, Delfina ; Motolese, Marta ; Nicoletti, Ferdinando ; Girardi, Paolo ; Sani, Gabriele. / Neurodevelopment in schizophrenia : The role of the wnt pathways. In: Current Neuropharmacology. 2013 ; Vol. 11, No. 5. pp. 535-558.
@article{ec37772dd8a74d3face1f27c19549266,
title = "Neurodevelopment in schizophrenia: The role of the wnt pathways",
abstract = "Objectives. To review the role of Wnt pathways in the neurodevelopment of schizophrenia. Methods: Systematic PubMed search, using as keywords all the terms related to the Wnt pathways and crossing them with each of the following areas: normal neurodevelopment and physiology, neurodevelopmental theory of schizophrenia, schizophrenia, and antipsychotic drug action. Results: Neurodevelopmental, behavioural, genetic, and psychopharmacological data point to the possible involvement of Wnt systems, especially the canonical pathway, in the pathophysiology of schizophrenia and in the mechanism of antipsychotic drug action. The molecules most consistently found to be associated with abnormalities or in antipsychotic drug action are Akt1, glycogen synthase kinase3beta, and beta-catenin. However, the extent to which they contribute to the pathophysiology of schizophrenia or to antipsychotic action remains to be established. Conclusions: The study of the involvement of Wnt pathway abnormalities in schizophrenia may help in understanding this multifaceted clinical entity; the development of Wnt-related pharmacological targets must await the collection of more data.",
keywords = "Antipsychotic drugs, Neurodevelopment, Schizophrenia, Wingless (wnt) signalling",
author = "Isabella Panaccione and Flavia Napoletano and Forte, {Alberto Maria} and Kotzalidis, {Giorgio D.} and {Del Casale}, Antonio and Chiara Rapinesi and Chiara Brugnoli and Daniele Serata and Federica Caccia and Ilaria Cuomo and Elisa Ambrosi and Alessio Simonetti and Valeria Savoja and {De Chiara}, Lavinia and Emanuela Danese and Giovanni Manfredi and Delfina Janiri and Marta Motolese and Ferdinando Nicoletti and Paolo Girardi and Gabriele Sani",
year = "2013",
month = "9",
doi = "10.2174/1570159X113119990037",
language = "English",
volume = "11",
pages = "535--558",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Neurodevelopment in schizophrenia

T2 - The role of the wnt pathways

AU - Panaccione, Isabella

AU - Napoletano, Flavia

AU - Forte, Alberto Maria

AU - Kotzalidis, Giorgio D.

AU - Del Casale, Antonio

AU - Rapinesi, Chiara

AU - Brugnoli, Chiara

AU - Serata, Daniele

AU - Caccia, Federica

AU - Cuomo, Ilaria

AU - Ambrosi, Elisa

AU - Simonetti, Alessio

AU - Savoja, Valeria

AU - De Chiara, Lavinia

AU - Danese, Emanuela

AU - Manfredi, Giovanni

AU - Janiri, Delfina

AU - Motolese, Marta

AU - Nicoletti, Ferdinando

AU - Girardi, Paolo

AU - Sani, Gabriele

PY - 2013/9

Y1 - 2013/9

N2 - Objectives. To review the role of Wnt pathways in the neurodevelopment of schizophrenia. Methods: Systematic PubMed search, using as keywords all the terms related to the Wnt pathways and crossing them with each of the following areas: normal neurodevelopment and physiology, neurodevelopmental theory of schizophrenia, schizophrenia, and antipsychotic drug action. Results: Neurodevelopmental, behavioural, genetic, and psychopharmacological data point to the possible involvement of Wnt systems, especially the canonical pathway, in the pathophysiology of schizophrenia and in the mechanism of antipsychotic drug action. The molecules most consistently found to be associated with abnormalities or in antipsychotic drug action are Akt1, glycogen synthase kinase3beta, and beta-catenin. However, the extent to which they contribute to the pathophysiology of schizophrenia or to antipsychotic action remains to be established. Conclusions: The study of the involvement of Wnt pathway abnormalities in schizophrenia may help in understanding this multifaceted clinical entity; the development of Wnt-related pharmacological targets must await the collection of more data.

AB - Objectives. To review the role of Wnt pathways in the neurodevelopment of schizophrenia. Methods: Systematic PubMed search, using as keywords all the terms related to the Wnt pathways and crossing them with each of the following areas: normal neurodevelopment and physiology, neurodevelopmental theory of schizophrenia, schizophrenia, and antipsychotic drug action. Results: Neurodevelopmental, behavioural, genetic, and psychopharmacological data point to the possible involvement of Wnt systems, especially the canonical pathway, in the pathophysiology of schizophrenia and in the mechanism of antipsychotic drug action. The molecules most consistently found to be associated with abnormalities or in antipsychotic drug action are Akt1, glycogen synthase kinase3beta, and beta-catenin. However, the extent to which they contribute to the pathophysiology of schizophrenia or to antipsychotic action remains to be established. Conclusions: The study of the involvement of Wnt pathway abnormalities in schizophrenia may help in understanding this multifaceted clinical entity; the development of Wnt-related pharmacological targets must await the collection of more data.

KW - Antipsychotic drugs

KW - Neurodevelopment

KW - Schizophrenia

KW - Wingless (wnt) signalling

UR - http://www.scopus.com/inward/record.url?scp=84884275360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884275360&partnerID=8YFLogxK

U2 - 10.2174/1570159X113119990037

DO - 10.2174/1570159X113119990037

M3 - Article

AN - SCOPUS:84884275360

VL - 11

SP - 535

EP - 558

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 5

ER -